iData provides dentistry market research reports on the diagnosis, prevention, and treatment of diseases and conditions of the oral cavity. iData’s dentistry market research includes coverage of bone graft substitutes, dental cements, dental hygiene, dental imaging, dental materials, overdentures, dental prosthetics, digital dentistry (CAD / CAM equipment devices) and materials as well as other dental devices and procedures.
By 2020, the European dental soft tissue regeneration market size was valued at €7.3 million, there were over 50,000 dental soft tissue procedures performed. Depending on the severity of COVID19 impact, the market size is expected to increase and reach somewhere between €8.5 and €9.9 million in 2026. Throughout this medical market research, we analyzed
This Global Report Series represents iData’s entire collection of country-level reports in the Global Dental X-Ray Imaging market. Each of these reports may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are listed below, including the report’s base year: United States (2018) Europe (2018) China (2018) Global Dental
In 2021, the European CAD/CAM systems market size is estimated to reach €419 million, with the Chairside CAD/CAM System segment showing the fastest growth. The market for CAD/CAM systems includes CAD/CAM milling systems, standalone CAD/CAM scanners, chairside CAD/CAM systems, and intraoral scanners. The economic recovery is slow in parts of Europe, particularly in the south.
In 2021, the European CAD/CAM materials market size is projected to reach €389 million, with the CAD/CAM block segment showing the fastest growth. The digital dentistry market will be driven by the continuing transition from traditional dental prosthetics to those produced through CAD/CAM technology. As prices have declined, the benefits of using CAD/CAM technology have
In 2021, the US dental 3D printer market size is estimated to reach $100 million, with the Resin Printer market expected to experience the fastest growth. In spite of COVID19, the US market size is projected to increase over the forecast period to reach nearly $144 billion in 2027. Currently, over 35% of the US
Industry Trends Growth of the denture market is dictated by a couple of factors, including the aging population. The elderly population in the United States consists of the largest demographic of edentulous patients. As such, growth of the elderly population will increase the potential volume of patients for denture procedures, thereby stimulating market growth. In
In 2019, the European cone beam computed tomography market size was valued at €165 million, with the large FOV CBCT market showing the fastest growth. With the emergence of CBCT technology, the CBCT scanner market has experienced rapid growth as the applications have expanded beyond 3D reconstructions of a patient’s facial structure to include pan/ceph
In 2019, the European surgical guides market size reached €35 million and is forecasted to exceed €63 million in 2026. Dentists use computer-guided surgery in one of two ways to assist them in the proper placement of implants: they either use treatment planning software exclusively or use the software along with a surgical guide. Due
In 2019, the European treatment planning software market size was valued at €16 million, with the U.K. market showing the most promising growth. The treatment planning software market is characterized by aggressive ASP declines, resulting in relatively flat growth in terms of value. Treatment planning software is a relatively costly investment that holds the promise
All-tissue lasers are systems that can be used on both soft and hard tissue in the intraoral cavity. These lasers have unique clinical characteristics that surpass conventional tools such as scalpel and drill, thus having the potential to decrease the use of such tools and to create a high-tech atmosphere around the dental chair. The minimally invasive equipment makes patients much more comfortable, increases the efficiency, and therefore the return on investment for the dentist. Even though all-tissue lasers are fairly expensive investments for dentists, the short and long term benefits can quickly outweigh the initial expenditures, making them a valuable addition to dental practices.
The dental surgical laser market includes all-tissue and soft-tissue lasers. Dental surgical lasers result in operational benefits to dental practices by enhancing the appeal for patients to undergo treatments using modern technology over traditional methods. Dental surgical laser technology greatly enhances dentists efficiency and effectiveness of treatments as well as increases patient comfort and willingness to undergo uncomfortable procedures.
Soft-tissue lasers are dental lasers that are effective on tissues surrounding teeth and can be used to contour gingiva, sterilize the intraoral cavity and minimize bleeding during procedures. These lasers turn several dental procedures into painless, comfortable and rapid operations, significantly increasing patient satisfaction. Soft-tissue lasers can be categorized into diode, CO2 and Nd:YAG lasers.
Barrier membranes are a critical component to regeneration therapy and are aimed at restoring the form and function of the mouth. Commercially available on the market, barrier membranes function in dental surgeries to help retain bone grafting materials, to exclude epithelium and connective tissue from entering into sites of desired bone and ligament regeneration, or for the combination of these reasons. Whether restoring lost bone around teeth or implants, or in larger areas of the jaws affected by trauma or disease, too often there is inadequate gingival tissue to cover the membranes, leading to membrane exposure, extensive membrane contamination and procedural failure, which is unacceptable.
Dental growth factor and tissue engineering products is a broad category that encompasses products used for facilitating and enhancing bone regeneration. This includes growth factors and enamel matrix protein solutions. Platelet rich plasma (PRP) is also used for these purposes, but will not be considered within this report. Osteoinductivity refers to the ability of a graft to induce de novo bone growth with biomimetic substances. However, only a few bone graft substitute materials have the capacity for osteoinductivity. Growth factors and other tissue engineering products enhance osteoinductivity and osteogenesis, and are used to increase the rate and volume of bone regeneration.